Opiummorphine

According to the FDA label: Opium tincture is useful for the treatment of diarrhea.

73,383 adverse event reports submitted to the FDA (1998–2026)

This data reflects voluntary reports submitted to the FDA's Adverse Event Monitoring System (AEMS), formerly the FDA Adverse Event Reporting System (FAERS). A report does not mean the medication caused the event. Data may be incomplete or contain errors. Learn more about AEMS. New to this data? Read our guide on how to interpret FDA adverse event reports →
New to FDA adverse event data? Here's how to read these reports →

Top Reported Adverse Events

The most frequently reported events in association with Opium in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.

Show these terms with plain-language definitions

Tap any term below for a plain-language definition.

Browse the full glossary →

Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.

Who Is Reporting

Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.

By Sex

View reporter sex data as a table
Opium adverse event reports by reporter sex
SexReports
Female36,588
Male30,925
Unknown295

By Age Group

View age group data as a table
Opium adverse event reports by reporter age group
Age groupReports
0-173,284
18-346,376
35-4910,355
50-6416,721
65-749,469
75+6,499

This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.

Reported Outcomes

Outcomes recorded in FAERS reports that included Opium. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.

View outcome data as a table
Opium adverse event reports by reported outcome
OutcomeReports
Other Serious35,737
Hospitalization30,321
Death20,146
Non-Serious9,481
Life-Threatening6,446
Disability2,473

Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.

Number of FAERS reports received per quarter for Opium. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.

View report trend as a table
Opium adverse event reports by year
YearReports
19982
19994
20011
20033
20041,022
20051,300
20061,351
20071,261
20081,665
20091,681
20102,271
20112,538
20123,131
20133,068
20143,448
20153,866
20164,113
20174,292
20184,899
20195,326
20205,967
20215,202
20224,286
20234,474
20244,214
20253,311
2026 (partial)687

The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.

Medications commonly reported with Opium

In FDA adverse event reports that mention Opium, these medications appeared most often in the same report.

This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.

Other medications with similar adverse event profiles in FDA FAERS reports.

Data Source

This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.

View this data on the FDA website →

Data last updated: June 2026